Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Instem (INS) Ord 10p

Sell:900.00p Buy:910.00p 0 Change: 12.50p (1.40%)
Market closed Prices as at close on 17 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:900.00p
Buy:910.00p
Change: 12.50p (1.40%)
Market closed Prices as at close on 17 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:900.00p
Buy:910.00p
Change: 12.50p (1.40%)
Market closed Prices as at close on 17 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Instem plc is a supplier of information technology (IT) applications to the early development healthcare market delivering solutions for data collection, management and analysis across the research and development continuum. The Company is engaged in Global Life Sciences operations. Its lead product suite, Provantis, is an application in the Early Development Safety Assessment (EDSA) market. The Provantis solution incorporates a suite of modules required for managing and recording EDSA studies, from receipt of the compound through to the automated assembly of statistical analyses and final reports. Its software allows scientific staff to collect, analyze and share data across the organization and externally. It also offers ALPHADAS, an early phase clinical software solution. The Company offers Centrus suite, which provides pre-built applications, as well as the ability to utilize a range of business intelligence and analysis tools.

Contact details

Address:
Diamond Way, Stone Business Park
STONE
ST15 0SD
United Kingdom
Telephone:
+44 (01785) 825600
Website:
www.instem.com/

Important dates

Future events
Interim results 27 September 2021 27/09/21
Past events
Trading Announcement 19 July 2021 19/07/21
AGM 27 May 2021 27/05/21
Final results 12 April 2021 12/04/21
Trading Announcement 14 January 2021 14/01/21
Interim results 28 September 2020 28/09/20

General stock information

EPIC:
INS
ISIN:
GB00B3TQCK30
Market cap:
£200.37 million
Shares in issue:
22.14 million
Sector:
Software & Computer Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Philip Reason
    Chief Executive Officer, Executive Director
  • Nigel Goldsmith
    Chief Financial Officer, Company Secretary, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.